AKT1 and retinoblastoma: Similarly, Yan et al. observed that suppressing the RRS1 gene in retinoblastoma cells inhibited cell proliferation and invasion through the protein kinase B (AKT)/mechanistic target of the rapamycin (mTOR) pathway [16].